Hirofumi Kurokawa

1.7k total citations
22 papers, 770 citations indexed

About

Hirofumi Kurokawa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hirofumi Kurokawa has authored 22 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hirofumi Kurokawa's work include Blood Pressure and Hypertension Studies (6 papers), Cardiovascular Health and Disease Prevention (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Hirofumi Kurokawa is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Cardiovascular Health and Disease Prevention (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Hirofumi Kurokawa collaborates with scholars based in Japan and United States. Hirofumi Kurokawa's co-authors include Seigo Sugiyama, Junichi Matsubara, Koichi Kaikita, Hisao Ogawa, Koichi Sugamura, Koichiro Fujisue, Hirofumi Maeda, Eiichi Akiyama, Hideaki Jinnouchi and Keisuke Ohba and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Medicine.

In The Last Decade

Hirofumi Kurokawa

19 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirofumi Kurokawa Japan 13 327 317 200 170 145 22 770
Eiichiro Yamamoto Japan 14 337 1.0× 189 0.6× 290 1.4× 141 0.8× 68 0.5× 34 946
Karoline von Websky Germany 16 149 0.5× 339 1.1× 164 0.8× 130 0.8× 171 1.2× 25 793
Mathias Burgmaier Germany 20 354 1.1× 283 0.9× 265 1.3× 420 2.5× 65 0.4× 55 1.0k
Motofumi Sasaki Japan 13 139 0.4× 334 1.1× 202 1.0× 177 1.0× 65 0.4× 16 781
Ornella Carbonara Italy 15 385 1.2× 383 1.2× 324 1.6× 189 1.1× 63 0.4× 22 998
Yuri Nishino Japan 16 96 0.3× 441 1.4× 202 1.0× 131 0.8× 101 0.7× 28 912
Hye Kyoung Song South Korea 17 133 0.4× 191 0.6× 213 1.1× 144 0.8× 132 0.9× 19 894
Lyubov Chaykovska Switzerland 14 147 0.4× 172 0.5× 101 0.5× 171 1.0× 84 0.6× 33 658
Tomoo Furumoto Japan 17 442 1.4× 189 0.6× 170 0.8× 149 0.9× 45 0.3× 34 888
Kenji Mizuno Japan 16 282 0.9× 227 0.7× 302 1.5× 248 1.5× 91 0.6× 82 867

Countries citing papers authored by Hirofumi Kurokawa

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Kurokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Kurokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Kurokawa more than expected).

Fields of papers citing papers by Hirofumi Kurokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Kurokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Kurokawa. The network helps show where Hirofumi Kurokawa may publish in the future.

Co-authorship network of co-authors of Hirofumi Kurokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Kurokawa. A scholar is included among the top collaborators of Hirofumi Kurokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Kurokawa. Hirofumi Kurokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Eiichiro, Hiroki Usuku, Daisuke Sueta, et al.. (2024). Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study. Advances in Therapy. 41(3). 1284–1303. 10 indexed citations
2.
Kurokawa, Hirofumi, et al.. (2022). Vaccination and Discrimination: Experimental Evidence under the COVID-19 Pandemic. SSRN Electronic Journal.
3.
4.
Nakamura, Shinichi, et al.. (2020). ‘Flower’ guiding catheter makes it possible to retrieve a ‘flared’ stent. BMJ Case Reports. 13(3). e234608–e234608. 1 indexed citations
5.
6.
7.
Kurokawa, Hirofumi, Seigo Sugiyama, Toshimitsu Nozaki, et al.. (2015). Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway. Atherosclerosis. 239(2). 375–385. 19 indexed citations
8.
Hirata, Yoshihiro, Eiichiro Yamamoto, Takanori Tokitsu, et al.. (2015). Reactive Oxygen Metabolites are Closely Associated With the Diagnosis and Prognosis of Coronary Artery Disease. Journal of the American Heart Association. 4(2). 32 indexed citations
9.
Kusaka, Hiroaki, Seigo Sugiyama, Eiichiro Yamamoto, et al.. (2015). Low-Normal Serum Sodium and Heart Failure-Related Events in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction. Circulation Journal. 80(2). 411–417. 18 indexed citations
10.
Misumi, Ikuo, Tsuyoshi Honda, Hirofumi Kurokawa, et al.. (2015). Systolic Flow Reversal in a Case of Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy. Internal Medicine. 54(14). 1765–1769. 1 indexed citations
11.
Maeda, Hirofumi, Seigo Sugiyama, Hideaki Jinnouchi, et al.. (2015). Advanced peripheral microvascular endothelial dysfunction and polyvascular disease in patients with high cardiovascular risk. Journal of Cardiology. 67(5). 455–462. 15 indexed citations
12.
Misumi, Ikuo, Tsuyoshi Honda, Hirofumi Kurokawa, et al.. (2015). Markedly High B-type Natriuretic Peptide Level in a Patient with Duchenne Muscular Dystrophy and Left Ventricular Non-Compaction. Internal Medicine. 54(17). 2197–2200. 5 indexed citations
13.
Fujisue, Koichiro, Seigo Sugiyama, Yasushi Matsuzawa, et al.. (2015). Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction. Circulation Journal. 79(12). 2623–2631. 41 indexed citations
14.
Hirata, Yoshihiro, Eiichiro Yamamoto, Takanori Tokitsu, et al.. (2015). The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease. Medicine. 94(25). e1040–e1040. 19 indexed citations
15.
Hirata, Yoshihiro, Seigo Sugiyama, Eiichiro Yamamoto, et al.. (2014). Endothelial function and cardiovascular events in chronic kidney disease. International Journal of Cardiology. 173(3). 481–486. 47 indexed citations
16.
Matsubara, Junichi, Seigo Sugiyama, Toshimitsu Nozaki, et al.. (2014). Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction. Journal of the American Heart Association. 3(4). 27 indexed citations
17.
Fujisue, Koichiro, Seigo Sugiyama, Hisayo Yasuda, et al.. (2013). Abstract 12311: Impairment of Peripheral Endothelial Function in Patients With Aortic Valve Stenosis in the Aging Population. Circulation.
18.
Matsuzawa, Yasushi, Seigo Sugiyama, Koichi Sugamura, et al.. (2013). Successful Diet and Exercise Therapy as Evaluated on Self-Assessment Score Significantly Improves Endothelial Function in Metabolic Syndrome Patients. Circulation Journal. 77(11). 2807–2815. 29 indexed citations
19.
Fujisue, Koichiro, Seigo Sugiyama, Takamichi Ono, et al.. (2013). Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease. Circulation Cardiovascular Interventions. 6(4). 452–459. 15 indexed citations
20.
Matsubara, Junichi, Seigo Sugiyama, Koichi Sugamura, et al.. (2012). A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice. Journal of the American College of Cardiology. 59(3). 265–276. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eiichiro Yamamoto Breakdown of academic impact, for papers by Karoline von Websky Breakdown of academic impact, for papers by Mathias Burgmaier Breakdown of academic impact, for papers by Motofumi Sasaki Breakdown of academic impact, for papers by Ornella Carbonara Breakdown of academic impact, for papers by Yuri Nishino Breakdown of academic impact, for papers by Hye Kyoung Song Breakdown of academic impact, for papers by Lyubov Chaykovska Breakdown of academic impact, for papers by Tomoo Furumoto Breakdown of academic impact, for papers by Kenji Mizuno
Rankless by CCL
2026